Clinical Trial Update: 18F-Fluciclovine PET and Multiparametric MR Imaging [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating 18F-Fluciclovine PET with multiparametric MRI for recurrent brain tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• 18F-Fluciclovine (fluorine-18-fluciclovine)

Snippet

Sponsor: Loma Linda University | Conditions: Brain Tumor, Recurrent, Adult | Phase 2 | Status: WITHDRAWN